Log in

Cytocore Stock Price, News & Analysis (OTCMKTS:MDIT)

+0.03 (+76.92 %)
(As of 10/23/2019 08:00 AM ET)
Today's Range
Now: $0.07
50-Day Range
MA: $0.05
52-Week Range
Now: $0.07
Volume500 shs
Average Volume581 shs
Market Capitalization$5.95 million
P/E RatioN/A
Dividend YieldN/A
MEDITE Cancer Diagnostics, Inc. operates as a medical technology company. It develops, manufactures, and markets molecular biomarkers, medical devices, and consumables for the detection, risk assessment, and diagnosis of cancerous and precancerous conditions and related diseases. The company offers USE 33, an ultrasonic decalcification instrument that automatically runs the process under controlled temperatures; TPC 15 Duo and Trio, a tissue processing instrument; TES 99 and TES Valida cooling units; and M530, A550, M380 microtomes for tissue sectioning. It also provides M630, a freezing microtome; TST44, a robotic multi-staining system; COT 20, a linear staining system; and RCM 9000, ACS 720, and TWISTER robotic coverslippers. In addition, the company develops SoftKit device for the self-collection of a sample that can be evaluated to provide an assessment of the health of the entire female genital tract. It sells its products through direct sales and distributors in the United States, China, Europe, and North Africa. The company serves histology and cytology laboratories associated with hospitals or research institutions, and independent laboratories. MEDITE Cancer Diagnostics, Inc. is headquartered in Orlando, Florida.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolOTCMKTS:MDIT



Sales & Book Value

Annual Sales$6.81 million
Book Value$0.17 per share



Market Cap$5.95 million
Next Earnings Date11/13/2019 (Estimated)
OptionableNot Optionable

Receive MDIT News and Ratings via Email

Sign-up to receive the latest news and ratings for MDIT and its competitors with MarketBeat's FREE daily newsletter.

Cytocore (OTCMKTS:MDIT) Frequently Asked Questions

What is Cytocore's stock symbol?

Cytocore trades on the OTCMKTS under the ticker symbol "MDIT."

When is Cytocore's next earnings date?

Cytocore is scheduled to release their next quarterly earnings announcement on Wednesday, November 13th 2019. View Earnings Estimates for Cytocore.

Has Cytocore been receiving favorable news coverage?

Press coverage about MDIT stock has trended negative this week, according to InfoTrie. The research firm ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Cytocore earned a daily sentiment score of -2.5 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the near term. View News Stories for Cytocore.

Who are some of Cytocore's key competitors?

What other stocks do shareholders of Cytocore own?

Who are Cytocore's key executives?

Cytocore's management team includes the folowing people:
  • Mr. Jeffrey Rencher, Chief Marketing & Bus. Devel. Officer (Age 52)
  • Ms. Susan Weisman, Consultant (Age 58)
  • Mr. Elmar A. Dave, Chief Exec. Officer

How do I buy shares of Cytocore?

Shares of MDIT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Cytocore's stock price today?

One share of MDIT stock can currently be purchased for approximately $0.07.

How big of a company is Cytocore?

Cytocore has a market capitalization of $5.95 million and generates $6.81 million in revenue each year. Cytocore employs 69 workers across the globe.View Additional Information About Cytocore.

What is Cytocore's official website?

The official website for Cytocore is http://www.medite-group.com/.

How can I contact Cytocore?

Cytocore's mailing address is 4203 SW 34TH STREET, ORLANDO FL, 32811. The company can be reached via phone at 407-996-9630 or via email at [email protected]

MarketBeat Community Rating for Cytocore (OTCMKTS MDIT)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  45 (Vote Outperform)
Underperform Votes:  43 (Vote Underperform)
Total Votes:  88
MarketBeat's community ratings are surveys of what our community members think about Cytocore and other stocks. Vote "Outperform" if you believe MDIT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDIT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel